HomeClinics HomeAbout ClinicsAll ClinicsHot TopicsAdvancesSpecial OffersCME
Logo
Search for

Volume 17, Issue 4, Pages 633-637 (November 2009)


View previous. 15 of 16 View next.

Discussion Regarding Botulinum Toxin, Immunologic Considerations with Long-term Repeated Use, with Emphasis on Cosmetic Applications

Gary Borodic, MD

Discussion Regarding Botulinum Toxin, Immunologic Considerations with Long-term Repeated Use, with Emphasis on Cosmetic Applications

Published in February 2007 Facial Plastic Surgery Clinics

Gary Borodic is a consultant for Mentor Corporation (a Johnson and Johnson Company)

 a Biologicals Science and Technology, Ash Road, Ipsen Biopharm Limited, Wrexham LL139UF, UK

 b Ipsen Pharma GmbH, Einsteinstrasse 30, Ettlingen D-76275, Germany

  Corresponding author. E-mail address: andy.pickett@ipsen.com

PII: S1064-7406(09)00095-9

doi:10.1016/j.fsc.2009.07.003


View previous. 15 of 16 View next.